Yıl: 2020 Cilt: 23 Sayı: 6 Sayfa Aralığı: 342 - 348 Metin Dili: İngilizce İndeks Tarihi: 17-11-2020

Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy

Öz:
Objective: The purpose of this study was to determine the effects of surgical resection of muscle layer on the long-term survival of patients withhypertrophic obstructive cardiomyopathy (HOCM).Methods: The original study cohort consisted of 552 patients with hypertrophic cardiomyopathy (HCM), including 380 patients with HOCM and172 patients with nonobstructive HCM. All these patients had a definite diagnosis in our center from October 1, 2009, to December 31, 2012. Theywere divided into three groups, viz., HOCM with myectomy group (n=194), nonoperated HOCM group (n=186), and nonobstructive HCM group(n=172). Median follow-up duration was 57.57±13.71 months, and the primary end point was a combination of mortality from all causes.Results: In this survival study, we compared the prognoses of patients with HOCM after myectomy, patients with nonoperated HOCM, andpatients with nonobstructive HCM. Among the three groups, the myectomy group showed a lower rate of reaching the all-cause mortality withstatistically indistinguishable overall survival compared with patients with nonobstructive HCM (p=0.514). Among patients with left ventricularoutflow tract (LVOT) obstruction, the overall survival in the myectomy group was noticeably better than that in the nonoperated HOCM group(log-rank p<0.001). Parameters that showed a significant univariate correlation with survival included age, previous atrial fibrillation (AF), NTproBNP, Cr, myectomy, and LV ejection fraction. When these variables were entered in the multivariate model, the only independent predictorsof survival were myotomy [hazard ratio (HR): 0.109; 95% CI: 0.013–0.877, p<0.037], age (HR: 1.047; 95% CI: 1.007–1.088, p=0.021), and previous AF(HR: 2.659; 95% CI: 1.022–6.919, p=0.021).Conclusion: Patients with HOCM undergoing myectomy appeared to suffer from a lower risk of reaching the all-cause mortality and demonstrated statistically indistinguishable overall survival compared with patients with nonobstructive HCM. Multivariate analysis clearly demonstratedmyectomy as a powerful, independent factor of survival, confirming that the differences in long-term survival recorded in this study may be dueto surgical improvement in the LVOT gradient. (Anatol J Cardiol 2020; 23: 342-8)
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 2015; 65: 1249-54.
  • 2. Sen-Chowdhry S, Jacoby D, Moon JC, McKenna WJ. Update on hypertrophic cardiomyopathy and a guide to the guidelines. Nat Rev Cardiol 2016; 13: 651-75.
  • 3. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet 2013; 381: 242-55.
  • 4. Nagueh SF, Groves BM, Schwartz L, Smith KM, Wang A, Bach RG, et al. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. J Am Coll Cardiol 2011; 58: 2322-8.
  • 5. Ball W, Ivanov J, Rakowski H, Wigle ED, Linghorne M, Ralph-Edwards A, et al. Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment. J Am Coll Cardiol 2011; 58: 2313-21.
  • 6. Kirklin JW, Ellis FH Jr. Surgical relief of diffuse subvalvular aortic stenosis. Circulation 1961; 24: 739-42.
  • 7. Morrow AG, Reitz BA, Epstein SE, Henry WL, Conkle DM, Itscoitz SB, et al. Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation 1975; 52: 88-102.
  • 8. Schönbeck MH, Brunner-La Rocca HP, Vogt PR, Lachat ML, Jenni R, Hess OM, et al. Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. Ann Thorac Surg 1998; 65: 1207-14.
  • 9. Merrill WH, Friesinger GC, Graham TP Jr, Byrd BF 3rd, Drinkwater DC Jr, Christian KG, et al. Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 2000; 69: 1732-5.
  • 10. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al.; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124: e783-831.
  • 11. Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733-79.
  • 12. Zhang K, Meng X, Wang W, Zheng J, An S, Wang S, et al. Prognostic Value of Free Triiodothyronine Level in Patients With Hypertrophic Obstructive Cardiomyopathy. J Clin Endocrinol Metab 2018; 103: 1198-205.
  • 13. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 46: 470-6.
  • 14. Woo A, Williams WG, Choi R, Wigle ED, Rozenblyum E, Fedwick K, et al. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 2005; 111: 2033-41.
  • 15. Smedira NG, Lytle BW, Lever HM, Rajeswaran J, Krishnaswamy G, Kaple RK, et al. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 2008; 85: 127-33.
  • 16. Desai MY, Bhonsale A, Smedira NG, Naji P, Thamilarasan M, Lytle BW, et al. Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction. Circulation 2013; 128: 209-16.
  • 17. Sedehi D, Finocchiaro G, Tibayan Y, Chi J, Pavlovic A, Kim YM, et al. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy. J Cardiol 2015; 66: 57-62.
  • 18. Liebregts M, Vriesendorp PA, Mahmoodi BK, Schinkel AF, Michels M, ten Berg JM. A Systematic Review and Meta-Analysis of LongTerm Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy. JACC Heart Fail 2015; 3: 896-905.
  • 19. Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Nishimura RA, et al. Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction. J Am Coll Cardiol 2015; 66: 1307-8.
  • 20. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al.; Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003; 42: 1687-713.
  • 21. van der Lee C, Kofflard MJ, van Herwerden LA, Vletter WB, ten Cate FJ. Sustained improvement after combined anterior mitral leaflet extension and myectomy in hypertrophic obstructive cardiomyopathy. Circulation 2003; 108: 2088-92.
  • 22. Ommen SR, Thomson HL, Nishimura RA, Tajik AJ, Schaff HV, Danielson GK. Clinical predictors and consequences of atrial fibrillation after surgical myectomy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 2002; 89: 242-4.
  • 23. Ommen SR, Park SH, Click RL, Freeman WK, Schaff HV, Tajik AJ. Impact of intraoperative transesophageal echocardiography in the surgical management of hypertrophic cardiomyopathy. Am J Cardiol 2002; 90: 1022-4.
  • 24. Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001; 38: 1701-6.
  • 25. Qin JX, Shiota T, Lever HM, Kapadia SR, Sitges M, Rubin DN, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001; 38: 1994-2000.
APA Meng X, LIANG M, SHI Y, ZHOU S, ZHANG W, GAO C (2020). Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy. , 342 - 348.
Chicago Meng Xiangbin,LIANG Mingyu,SHI Yong-en,ZHOU Sijie,ZHANG Weijie,GAO Chuanyu Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy. (2020): 342 - 348.
MLA Meng Xiangbin,LIANG Mingyu,SHI Yong-en,ZHOU Sijie,ZHANG Weijie,GAO Chuanyu Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy. , 2020, ss.342 - 348.
AMA Meng X,LIANG M,SHI Y,ZHOU S,ZHANG W,GAO C Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy. . 2020; 342 - 348.
Vancouver Meng X,LIANG M,SHI Y,ZHOU S,ZHANG W,GAO C Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy. . 2020; 342 - 348.
IEEE Meng X,LIANG M,SHI Y,ZHOU S,ZHANG W,GAO C "Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy." , ss.342 - 348, 2020.
ISNAD Meng, Xiangbin vd. "Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy". (2020), 342-348.
APA Meng X, LIANG M, SHI Y, ZHOU S, ZHANG W, GAO C (2020). Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy. The Anatolian Journal of Cardiology, 23(6), 342 - 348.
Chicago Meng Xiangbin,LIANG Mingyu,SHI Yong-en,ZHOU Sijie,ZHANG Weijie,GAO Chuanyu Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy. The Anatolian Journal of Cardiology 23, no.6 (2020): 342 - 348.
MLA Meng Xiangbin,LIANG Mingyu,SHI Yong-en,ZHOU Sijie,ZHANG Weijie,GAO Chuanyu Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy. The Anatolian Journal of Cardiology, vol.23, no.6, 2020, ss.342 - 348.
AMA Meng X,LIANG M,SHI Y,ZHOU S,ZHANG W,GAO C Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy. The Anatolian Journal of Cardiology. 2020; 23(6): 342 - 348.
Vancouver Meng X,LIANG M,SHI Y,ZHOU S,ZHANG W,GAO C Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy. The Anatolian Journal of Cardiology. 2020; 23(6): 342 - 348.
IEEE Meng X,LIANG M,SHI Y,ZHOU S,ZHANG W,GAO C "Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy." The Anatolian Journal of Cardiology, 23, ss.342 - 348, 2020.
ISNAD Meng, Xiangbin vd. "Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy". The Anatolian Journal of Cardiology 23/6 (2020), 342-348.